Skip to content
Luna Metabolic
Menu

Head-to-head for women

Effecty vs yourEra

Effecty and yourEra both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

Effecty

Higher score

Ranked #20 for women · Grade B+

Best for: Women who want the flexibility of both compounded and FDA-approved brand medication from a LegitScript-accredited, nationwide provider.

Visit Effecty
vs

yourEra

Ranked #3 for women · Grade B

Best for: Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account.

Visit yourEra

The verdict for women

Higher Luna Fit Score: Effecty

Effecty edges out yourEra on the Luna Fit Score, 87 to 86 (B+ vs B). Women who want the flexibility of both compounded and FDA-approved brand medication from a LegitScript-accredited, nationwide provider. The reasoning behind that number is in our Effecty write-up for women.

yourEra is still a genuine option — both molecules at prices you can see up front, wrapped in a wider menu — NAD+, microdosing, and an optional coaching-and-labs bundle — for a woman who wants weight care and energy alongside it. Weigh the six women's-health factors below against your own priorities; our full yourEra review goes through each of them, and if neither of these two is the one, the yourEra alternatives, scored on the same six factors widens the field.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

Effecty yourEra
PCOS & hormonal suitability8684
Effecty
yourEra
Clinical oversight & labs8885
Effecty
yourEra
Price transparency8588
Effecty
yourEra
Nationwide access9590
Effecty
yourEra
Ongoing support8486
Effecty
yourEra
Cancellation fairness8382
Effecty
yourEra

Price, access & features

DetailEffectyyourEra
Luna Fit Score87/100 · B+86/100 · B
Overall rank#20#3
Semaglutide$160/mo$199/mo
Tirzepatide$240/mo$299/mo
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only

Effecty

Ranked #20 · Grade B+

What we like

  • FDA-approved brand access plus compounded, both molecules
  • LegitScript-accredited — a meaningful oversight signal when hormones are involved
  • Nationwide across all 50 states

The caveats

  • No oral/sublingual form
  • Not a hormone-specialty program; PCOS framing is general

yourEra

Ranked #3 · Grade B

What we like

  • Publicly listed pricing on both molecules — semaglutide from $199/mo and tirzepatide from $299/mo — while many compounders hide price behind a quiz
  • Fuller menu beyond GLP-1: NAD+ and microdosing protocols, plus an optional membership adding 1:1 coaching, a nutritionist, and an at-home lab draw
  • Markets a 50-state licensed-clinician network, no insurance required, with HSA/FSA accepted

The caveats

  • Compounded semaglutide and tirzepatide are not FDA-approved the way brand Wegovy, Ozempic, or Zepbound are, and compounding access can tighten as brand shortages resolve
  • Mid-market pricing that sits above the cheapest compounders (roughly $99–$150)
  • Injectable only — no oral route and no brand-name lane

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Neither Effecty nor yourEra is only worth comparing with the other. Effecty is also written up against Vytora Health, an exact tie on the Luna Fit Score — see how Effecty and Vytora Health compare on the Luna Fit Score. yourEra is also written up against CoreAge Rx, 7 points apart — see how yourEra and CoreAge Rx compare on the Luna Fit Score.

Or browse the full comparison hub.